Impact of failed response to novel agent induction in autologous stem cell transplantation for multiple myeloma

Author： Lee Sung-Eun   Yoon Jae-Ho   Shin Seung-Hwan   Cho Byung-Sik   Eom Ki-Seong   Kim Yoo-Jin   Kim Hee-Je   Lee Seok   Cho Seok-Goo   Kim Dong-Wook   Lee Jong-Wook   Min Woo-Sung   Park Chong-Won   Min Chang-Ki  

Publisher： Springer Publishing Company

ISSN： 0939-5555

Source： Annals of Hematology, Vol.93, Iss.4, 2014-04, pp. : 627-634

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Stem cell transplantation in multiple myeloma

By Björkstrand Bo  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 26-28

Maney Publishing

Access to resources Recommend Favorite

Autologous peripheral blood stem cell transplantation in multiple myeloma using oral versus I.V. melphalan

By Vela-Ojeda J.   García-Ruiz-Esparza M.   Padilla-González Y.   Gómez-Almaguer D.   Gutiérrez-Aguirre C.   Gómez-Rangel D.   Morales-Toquero A.   Ruiz-Delgado G.   Delgado-Lamas J.   Ruiz-Argüelles G.  

Annals of Hematology, Vol. 86, Iss. 4, 2007-04 ,pp. : 277-282

Springer Publishing Company

Access to resources Recommend Favorite

A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma

By Chim C.   Lie A.   Chan E.   Leung Y.   Cheung S.   Chan S.   Liang Raymond   Kwong Y.  

Annals of Hematology, Vol. 89, Iss. 10, 2010-10 ,pp. : 1019-1027

Springer Publishing Company

Access to resources Recommend Favorite

Autologous peripheral stem cell transplantation for multiple myeloma in a patient with a 10 year-old kidney transplant - case report and clinical issues

By Rego F.   Alcantara P.   Buinho F.   Araujo F.   Costa Santos J.M.   Parreira A.   Leal da Costa F.  

Transplantation Proceedings, Vol. 35, Iss. 3, 2003-05 ,pp. : 1102-1104

Elsevier

Access to resources Recommend Favorite

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

By Hicks C.   Wong R.   Manoharan A.   Kwan Y.  

Annals of Hematology, Vol. 86, Iss. 8, 2007-08 ,pp. : 591-598

Springer Publishing Company

Access to resources Recommend Favorite